US Pharma MarketingThe post ERS 2026: AI lung imaging shows utility in detecting pulmonary fibrosis candidate’s efficacy appeared first on Medical Device Network.
ERS 2026: AI lung imaging shows utility in detecting pulmonary fibrosis candidate’s efficacy
Brainomix's e-Lung AI imaging tool was used to assess Endeavor's hedgehog pathway inhibitor, taladegib. Brainomix's e-Lung AI imaging tool was used to assess Endeavor's hedgehog pathway inhibitor, taladegib. ERS 2026 is taking place between 5-9 September in Barcelona, Spain. Credit: Butusova Elena/Shutterstock.com Brainomix’s AI-based quantitative lung imaging technology has been used to successfully detect therapeutic benefit in a clinical trial evaluating an experimental drug for a type of lung disease. The use of Brainomix 360 e-Lung, an AI-powered image analysis tool, was evaluated in a post-hoc analysis of Endeavor BioMedicine’s Phase IIa trial evaluating its hedgehog pathway inhibitor, taladegib, in…
Brainomix's e-Lung AI imaging tool was used to assess Endeavor's hedgehog pathway inhibitor, taladegib.
Source: Medical Device Network